Literature DB >> 11562071

Protective effects of a protein-bound polysaccharide, PSK, on Candida albicans infection in mice via tumor necrosis factor-alpha induction.

Y Ohmura1, K Matsunaga, I Motokawa, K Sakurai, T Ando.   

Abstract

We investigated the protective mechanism of a protein-bound polysaccharide, PSK, against lethal infection with Candida albicans (C. albicans) in mice. (1) In BALB/c mice inoculated intravenously with C. albicans, the intraperitoneal (ip) administration of PSK increased survival rates and prolonged the survival period depending on the time of administration, the dosage, and the size of fungal inoculum; the maximal effect was obtained when PSK 250 mg/kg was ip administered to mice 24 h before inoculation of 1 x 10(6) C. albicans (30 days survivors showed 60% and the mean survival period of mice with fatal infection increased 209%). (2) The protective effect of PSK was significantly decreased in mice treated with cyclophosphamide or carrageenan, or in mice treated previously with anti-tumor necrosis factor-alpha (TNF-alpha) antibody. (3) The administration of PSK significantly enhanced the expression of TNF-alpha gene in spleen and increased leukocyte functions from 6 h to 1 day after inoculation. (4) When the PSK fraction subjected to hydrolysis with beta1-3 glucanase or hydrazine was used instead of PSK, the anti-fungal activities were significantly decreased. These findings suggested that the protective effect of PSK on lethal C. albicans infection in mice was mainly produced via TNF-alpha functions, and that beta 1-3 glucan and protein moiety in PSK molecule were involved in the expression of the activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562071     DOI: 10.1016/s1567-5769(01)00104-7

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  4 in total

1.  Immunostimulating properties of intragastrically administered Acetobacter-derived soluble branched (1,4)-beta-D-glucans decrease murine susceptibility to Listeria monocytogenes.

Authors:  Wei Li; Toshiki Yajima; Kimika Saito; Hitoshi Nishimura; Takashi Fushimi; Yoshifumi Ohshima; Yoshinori Tsukamoto; Yasunobu Yoshikai
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  Aureobasidium-derived soluble branched (1,3-1,6) beta-glucan (Sophy beta-glucan) enhances natural killer activity in Leishmania amazonensis-infected mice.

Authors:  Lalani Yatawara; Susiji Wickramasinghe; Mitsuru Nagataki; Misa Takamoto; Haruka Nomura; Yasunori Ikeue; Yoshiya Watanabe; Takeshi Agatsuma
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

Review 3.  Trametes versicolor mushroom immune therapy in breast cancer.

Authors:  Leanna J Standish; Cynthia A Wenner; Erin S Sweet; Carly Bridge; Ana Nelson; Mark Martzen; Jeffrey Novack; Carolyn Torkelson
Journal:  J Soc Integr Oncol       Date:  2008

4.  Evaluation of widely consumed botanicals as immunological adjuvants.

Authors:  Govind Ragupathi; K Simon Yeung; Ping-Chung Leung; Mavis Lee; Clara Bik San Lau; Andrew Vickers; Chandra Hood; Gary Deng; Nai-Kong Cheung; Barrie Cassileth; Philip Livingston
Journal:  Vaccine       Date:  2008-07-18       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.